The Global COVID-19 Observatory and Resource Center for Childhood Cancer: A Response for the Pediatric Oncology Community by SIOP and St. Jude Global

Overview

Journal Pediatr Blood Cancer

Specialties Hematology
Oncology
Pediatrics

Date 2021 Feb 25

PMID 33629507

Citations 10

Authors

Daniel C Moreira

Elizabeth Sniderman

Sheena Mukkada

Guillermo Chantada

Nickhill Bhakta

Whitney Foster

Meghana Avula

Maysam R Homsi

Lane Faughnan

Brooke Happ

Allyson Andujar

Jason Sonnenfelt

Rashmi Dalvi

A Lindsay Frazier

Laila Hessissen

Pamela R Kearns

Sandra Luna-Fineman

Arturo Moreno

Muhammad Saghir Khan

Michael Sullivan

Meenakshi Devidas

Victor Santana

Miguela Caniza

Kathy Pritchard-Jones

Carlos Rodriguez-Galindo

Affiliations

Soon will be listed here.

Abstract

The COVID-19 pandemic quickly led to an abundance of publications and recommendations, despite a paucity of information on how COVID-19 affects children with cancer. This created a dire need for a trusted resource with curated information and a space for the pediatric oncology community to share experiences. The Global COVID-19 Observatory and Resource Center for Childhood Cancer was developed, launched, and maintained by the International Society of Pediatric Oncology and St. Jude Children's Research Hospital. The three components (Resource Library, Global Registry, and Collaboration Space) complement each other, establishing a mechanism to generate and transfer knowledge rapidly throughout the community.

Citing Articles

Profile and Outcomes of Pediatric Hematology and Oncology Patients Diagnosed with COVID-19 in the Philippine General Hospital.

Ong F, Yu H, Alcasabas A, Caneba J, Estanislao J, Fajardo P Acta Med Philipp. 2024; 58(7):163-169.

PMID: 38882910 PMC: 11168950. DOI: 10.47895/amp.v58i7.6865.

Impact of the COVID-19 pandemic on pediatric oncology providers globally: A mixed-methods study.

Sniderman E, Graetz D, Agulnik A, Ranadive R, Vedaraju Y, Chen Y Cancer. 2022; 128(7):1493-1502.

PMID: 35067925 PMC: 9015299. DOI: 10.1002/cncr.34090.

The impact of the COVID-19 pandemic in pediatric oncology units: A lesson of resilience and hope.

Baroni L, Bouffet E Cancer. 2022; 128(7):1363-1364.

PMID: 35067918 PMC: 9015345. DOI: 10.1002/cncr.34089.

COVID-19: Consequences for Children With Cancer in Turkey and Globally.

Kebudi R, Chantada G, Kurucu N, Tugcu D, Mukkada S, Moreira D Turk Arch Pediatr. 2022; 56(4):295-299.

PMID: 35005722 PMC: 8655955. DOI: 10.5152/TurkArchPediatr.2021.21134.

Improved anticancer activity of betulinic acid on breast cancer through a grafted copolymer-based micelles system.

Qi X, Gao C, Yin C, Fan J, Wu X, Guo C Drug Deliv. 2021; 28(1):1962-1971.

PMID: 34565273 PMC: 8475105. DOI: 10.1080/10717544.2021.1979125.

References

Bouffet E, Challinor J, Sullivan M, Biondi A, Rodriguez-Galindo C, Pritchard-Jones K . Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences. Pediatr Blood Cancer. 2020; 67(7):e28327. DOI: 10.1002/pbc.28327. View

Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung A . COVID-19 in Children With Cancer in New York City. JAMA Oncol. 2020; 6(9):1459-1460. PMC: 7221844. DOI: 10.1001/jamaoncol.2020.2028. View

Galvao J . COVID-19: the deadly threat of misinformation. Lancet Infect Dis. 2020; 21(5):e114. PMC: 7535539. DOI: 10.1016/S1473-3099(20)30721-0. View

Voss A, Coombs G, Unal S, Saginur R, Hsueh P . Publishing in face of the COVID-19 pandemic. Int J Antimicrob Agents. 2020; 56(1):106081. PMC: 7357502. DOI: 10.1016/j.ijantimicag.2020.106081. View

Yang C, Li C, Wang S . Clinical strategies for treating pediatric cancer during the outbreak of 2019 novel coronavirus infection. Pediatr Blood Cancer. 2020; 67(5):e28248. DOI: 10.1002/pbc.28248. View

Liang W, Guan W, Chen R, Wang W, Li J, Xu K . Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21(3):335-337. PMC: 7159000. DOI: 10.1016/S1470-2045(20)30096-6. View

Tangcharoensathien V, Calleja N, Nguyen T, Purnat T, DAgostino M, Garcia-Saiso S . Framework for Managing the COVID-19 Infodemic: Methods and Results of an Online, Crowdsourced WHO Technical Consultation. J Med Internet Res. 2020; 22(6):e19659. PMC: 7332158. DOI: 10.2196/19659. View

Moreira D, Sniderman E, Mukkada S, Chantada G, Bhakta N, Foster W . The Global COVID-19 Observatory and Resource Center for Childhood Cancer: A response for the pediatric oncology community by SIOP and St. Jude Global. Pediatr Blood Cancer. 2021; 68(5):e28962. PMC: 7994967. DOI: 10.1002/pbc.28962. View

Modjarrad K, Moorthy V, Millett P, Gsell P, Roth C, Kieny M . Developing Global Norms for Sharing Data and Results during Public Health Emergencies. PLoS Med. 2016; 13(1):e1001935. PMC: 4701443. DOI: 10.1371/journal.pmed.1001935. View

10.

Goulia P, Mantas C, Dimitroula D, Mantis D, Hyphantis T . General hospital staff worries, perceived sufficiency of information and associated psychological distress during the A/H1N1 influenza pandemic. BMC Infect Dis. 2010; 10:322. PMC: 2990753. DOI: 10.1186/1471-2334-10-322. View

11.

Vasquez L, Sampor C, Villanueva G, Maradiegue E, Garcia-Lombardi M, Gomez-Garcia W . Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America. Lancet Oncol. 2020; 21(6):753-755. PMC: 7234788. DOI: 10.1016/S1470-2045(20)30280-1. View

12.

Janssens G, Mandeville H, Timmermann B, Maduro J, Alapetite C, Padovani L . A rapid review of evidence and recommendations from the SIOPE radiation oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises. Radiother Oncol. 2020; 148:216-222. PMC: 7184972. DOI: 10.1016/j.radonc.2020.04.035. View

13.

Verbruggen L, Wang Y, Armenian S, Ehrhardt M, van der Pal H, van Dalen E . Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. 2020; 67(12):e28702. PMC: 7537044. DOI: 10.1002/pbc.28702. View

14.

Mehra M, Desai S, Ruschitzka F, Patel A . RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020; . PMC: 7255293. DOI: 10.1016/S0140-6736(20)31180-6. View

15.

Mehra M, Ruschitzka F, Patel A . Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020; 395(10240):1820. PMC: 7274621. DOI: 10.1016/S0140-6736(20)31324-6. View

16.

Sullivan M, Bouffet E, Rodriguez-Galindo C, Luna-Fineman S, Khan M, Kearns P . The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global. Pediatr Blood Cancer. 2020; 67(7):e28409. PMC: 7235469. DOI: 10.1002/pbc.28409. View